文献速递心血管胸部CT

定量CT血管造影评估主动脉瓣狭窄的瓣膜纤维钙化体积

Quantitative Computed Tomography Angiography for the Evaluation of Valvular Fibrocalcific Volume in Aortic Stenosis.
PubMed 文献 · JACC Cardiovasc Imaging · 2024-08-07

该研究在136例主动脉瓣狭窄患者中,于基线和1年后用CT血管造影计算纤维钙化体积,采用高斯混合模型分析CT衰减分布以区分钙化、非钙化和纤维钙化组织。纤维钙化体积测量与离体瓣膜重量相关(r=0.51),扫描-重扫描重现性好(平均差-1%),与超声平均压差相关(男性rho=0.64、女性rho=0.69),1年后增加17%并与平均压差进展相关(rho=0.32),基线纤维钙化体积是平均压差进展的最强预测因子(女性rho=0.75)。

要点

  • CT血管造影可定量主动脉瓣纤维钙化体积,扫描-重扫描平均差-1%,一致性界限-4.5%至2.8%。
  • 基线纤维钙化体积与超声平均压差相关:男性rho=0.64,女性rho=0.69,均P<0.001。
  • 男性以钙化体积驱动该关系,女性以纤维化体积驱动;基线纤维钙化体积是平均压差进展最强预测因子,女性rho=0.75。

核心结论

  • 主动脉瓣纤维钙化体积可对主动脉瓣狭窄严重程度进行解剖学评估,并能精确追踪疾病进展,在男性和女性患者中均与疾病严重程度及血流动力学进展相关。

研究设计与样本

  • 研究纳入136例主动脉瓣狭窄患者,在基线和1年后行CT血管造影计算纤维钙化体积,采用高斯混合模型分析CT衰减分布以推导组织类型阈值,量化钙化、非钙化和纤维钙化体积,并评估扫描-重扫描重现性、以组织学和外部队列(n=66)进行验证。

关键影像表现/征象

  • 纤维钙化体积测量耗时5.8±1.0分钟/次扫描,与离体瓣膜重量相关(r=0.51;P<0.001),扫描-重扫描重现性好(平均差-1%,一致性界限-4.5%至2.8%)。
  • 基线纤维钙化体积与超声平均压差相关:男性rho=0.64、女性rho=0.69(均P<0.001),外部队列(n=66)rho=0.58(P<0.001)。
  • 上述关系在男性主要由钙化体积驱动,在女性主要由纤维化体积驱动。
  • 1年后纤维钙化体积增加17%,并与平均压差进展相关(rho=0.32;P=0.003)。
  • 基线纤维钙化体积是后续平均压差进展的最强预测因子,女性患者中关联尤其强(rho=0.75;P<0.001)。

诊断标准与关键数值

  • 采用高斯混合模型分析CT衰减分布,推导组织类型阈值以量化钙化、非钙化和纤维钙化体积。
  • 纤维钙化体积与离体瓣膜重量相关r=0.51(P<0.001),扫描-重扫描平均差-1%、一致性界限-4.5%至2.8%。
  • 基线纤维钙化体积与超声平均压差相关:男性rho=0.64、女性rho=0.69(均P<0.001),外部队列(n=66)rho=0.58(P<0.001)。
  • 1年后纤维钙化体积增加17%,与平均压差进展相关rho=0.32(P=0.003);基线纤维钙化体积预测平均压差进展,女性rho=0.75(P<0.001)。

临床应用与阅片要点

  • CT血管造影可定量主动脉瓣纤维钙化体积,测量耗时5.8±1.0分钟/次扫描,扫描-重扫描重现性好(平均差-1%,一致性界限-4.5%至2.8%)。
  • 纤维钙化体积与超声平均压差相关,男性rho=0.64、女性rho=0.69(均P<0.001),外部队列(n=66)rho=0.58(P<0.001)。
  • 男性该关系主要由钙化体积驱动,女性主要由纤维化体积驱动;基线纤维钙化体积是平均压差进展最强预测因子,女性rho=0.75(P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Aortic stenosis (AS) is characterized by calcification and fibrosis. The ability to quantify these processes simultaneously has been limited with previous imaging methods.

OBJECTIVES: The purpose of this study was to evaluate the aortic valve fibrocalcific volume by computed tomography (CT) angiography in patients with AS, in particular, to assess its reproducibility, association with histology and disease severity, and ability to predict/track progression.

METHODS: In 136 patients with AS, fibrocalcific volume was calculated on CT angiograms at baseline and after 1 year. CT attenuation distributions were analyzed using Gaussian-mixture-modeling to derive thresholds for tissue types enabling the quantification of calcific, noncalcific, and fibrocalcific volumes. Scan-rescan reproducibility was assessed and validation provided against histology and in an external cohort.

RESULTS: Fibrocalcific volume measurements took 5.8 ± 1.0 min/scan, demonstrating good correlation with ex vivo valve weight (r = 0.51; P < 0.001) and excellent scan-rescan reproducibility (mean difference -1%, limits of agreement -4.5% to 2.8%). Baseline fibrocalcific volumes correlated with mean gradient on echocardiography in both male and female participants (rho = 0.64 and 0.69, respectively; both P < 0.001) and in the external validation cohort (n = 66, rho = 0.58; P < 0.001). The relationship was driven principally by calcific volume in men and fibrotic volume in women. After 1 year, fibrocalcific volume increased by 17% and correlated with progression in mean gradient (rho = 0.32; P = 0.003). Baseline fibrocalcific volume was the strongest predictor of subsequent mean gradient progression, with a particularly strong association in female patients (rho = 0.75; P < 0.001).

CONCLUSIONS: The aortic valve fibrocalcific volume provides an anatomic assessment of AS severity that can track disease progression precisely. It correlates with disease severity and hemodynamic progression in both male and female patients.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Lembo M, Joshi SS, Geers J, et al. Quantitative Computed Tomography Angiography for the Evaluation of Valvular Fibrocalcific Volume in Aortic Stenosis. JACC Cardiovasc Imaging. 2024. PMID: 39115499. doi:10.1016/j.jcmg.2024.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。